Vacuolar Protein Sorting 29 (VPS29) (N-Term) Peptide
-
- Target See all VPS29 products
- VPS29 (Vacuolar Protein Sorting 29 (VPS29))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-VPS29 antibody (Catalog #: ARP56858_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VPS29 (Vacuolar Protein Sorting 29 (VPS29))
- Background
-
This gene belongs to a group of vacuolar protein sorting (VPS) genes that, when functionally impaired, disrupt the efficient delivery of vacuolar hydrolases. The protein encoded by this gene is a component of a large multimeric complex, termed the retrome
Alias Symbols: DC15, DC7, DKFZp564F0223, FLJ20492, PEP11
Protein Interaction Partner: FRA10AC1,RGS2,VPS35,FRA10AC1,RGS2
Protein Size: 182 - Molecular Weight
- 20 kDa
- Gene ID
- 51699
- NCBI Accession
- NM_016226, NP_057310
- UniProt
- Q9UBQ0
-